End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
26.97 CNY | +0.37% |
|
-5.10% | -0.99% |
05-27 | Morgan Stanley Starts Pacific Shuanglin Bio-pharmacy at Overweight With 37 Yuan Price Target | MT |
05-23 | Pacific Shuanglin Bio-pharmacy's Unit Gets Nod to Trial Intravenous Human Immunoglobulin | MT |
Business Summary
Number of employees: 2,426
Sales per Business
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Blood
99.8
%
| 2,396 | 99.6 % | 2,324 | 99.8 % | -2.97% |
Others
0.1
%
| 10 | 0.4 % | 3 | 0.1 % | -65.97% |
Matrix Body
0.0
%
| - | - | 1 | 0.0 % | - |
Sales per region
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
98.4
%
| 2,292 | 95.3 % | 2,291 | 98.4 % | -0.04% |
Abroad
1.6
%
| 113 | 4.7 % | 37 | 1.6 % | -66.90% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ye Hong Wang
DFI | Director of Finance/CFO | 33 | 21-03-25 |
Xiao Ying Huang
BRD | Director/Board Member | 50 | 23-10-24 |
Yu Lin Zhao
SEC | Corporate Secretary | 37 | 19-05-20 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jun Yin
BRD | Director/Board Member | 69 | 23-10-24 |
Jin Gang Zhang
BRD | Director/Board Member | 61 | 12-10 |
Shao Lan Fu
CHM | Chairman | 82 | 12-10 |
Zuo Jun Dong
BRD | Director/Board Member | 54 | 21-03-22 |
Xiao Ying Huang
BRD | Director/Board Member | 50 | 23-10-24 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 736,580,544 | 403,975,412 ( 54.84 %) | 3,537,253 ( 0.4802 %) | 54.84 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
988,501 | 0.15% | 3,773,059 $ |
Company contact information
Pacific Shuanglin Bio-pharmacy Co., Ltd.
1, Xinfeng East Road Donghai Island, Dongjian Town
524072, Zhanjiang
+
http://www.slbiop.com![address Pacific Shuanglin Bio-pharmacy Co., LTD(000403)](https://cdn.zonebourse.com/static/address/20701673.png)
Sector
Sales per Business
Sales per region
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-0.99% | 2.71B | |
+2.97% | 94.74B | |
-4.08% | 37.28B | |
-13.26% | 32.68B | |
+74.78% | 27.72B | |
-11.58% | 16.19B | |
-1.66% | 13.88B | |
-11.67% | 11.58B | |
+190.36% | 10.92B | |
-52.61% | 9.54B |
- Stock Market
- Equities
- 000403 Stock
- Company Pacific Shuanglin Bio-pharmacy Co., LTD